Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to $720.0.

  • Legend Biotech's Shares Outstanding (Diluted Average) rose 2857.14% to $720.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $720.0, marking a year-over-year increase of 2857.14%. This contributed to the annual value of $293.2 million for FY2021, which is 1075.79% up from last year.
  • According to the latest figures from Q3 2025, Legend Biotech's Shares Outstanding (Diluted Average) is $720.0, which was up 2857.14% from $620.0 recorded in Q2 2025.
  • Legend Biotech's 5-year Shares Outstanding (Diluted Average) high stood at $308.7 million for Q1 2022, and its period low was $210.0 during Q2 2024.
  • Over the past 4 years, Legend Biotech's median Shares Outstanding (Diluted Average) value was $266293.9 (recorded in 2021), while the average stood at $129.9 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first crashed by 9986.69% in 2021, then surged by 11582417.96% in 2022.
  • Over the past 4 years, Legend Biotech's Shares Outstanding (Diluted Average) (Quarter) stood at $293.2 million in 2021, then increased by 5.29% to $308.7 million in 2022, then crashed by 100.0% to $560.0 in 2024, then increased by 28.57% to $720.0 in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $720.0 for Q3 2025, versus $620.0 for Q2 2025 and $560.0 for Q3 2024.